 |
50 Diseases |  |
0 Trials |
|
0 Trials |  |
43 News |  |
- | Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment change, Trial withdrawal: Pilot E2 for Hypogonadal Women With CFBD (clinicaltrials.gov) - Apr 18, 2019
P4, N=0, Withdrawn, Sponsor: Emory University
N=52 --> 0 | Recruiting --> Withdrawn
- | Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment open: Pilot E2 for Hypogonadal Women With CFBD (clinicaltrials.gov) - Feb 11, 2019
P4, N=52, Recruiting, Sponsor: Emory University
N=52 --> 0 | Recruiting --> Withdrawn Not yet recruiting --> Recruiting
- | Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
New P4 trial: Pilot E2 for Hypogonadal Women With CFBD (clinicaltrials.gov) - Oct 29, 2018
P4, N=52, Not yet recruiting, Sponsor: Emory University
- | Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment change: Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition (clinicaltrials.gov) - Oct 17, 2017
P=N/A, N=36, Completed, Sponsor: University of North Carolina, Chapel Hill
Not yet recruiting --> Recruiting N=30 --> 36
- | Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment closed, Trial primary completion date: Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone (clinicaltrials.gov) - Jun 1, 2017
P=N/A, N=13, Active, not recruiting, Sponsor: University of Virginia
N=30 --> 36 Completed --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Aug 2018
- | Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Trial completion: Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=30, Completed, Sponsor: University of North Carolina, Chapel Hill
Completed --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Aug 2018 Active, not recruiting --> Completed
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment closed: Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition (clinicaltrials.gov) - Jun 24, 2016
P=N/A, N=30, Active, not recruiting, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Trial primary completion date: Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition (clinicaltrials.gov) - May 6, 2016
P=N/A, N=30, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Active, not recruiting Trial primary completion date: Feb 2016 --> Oct 2016
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Trial termination, Metastases: Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy (clinicaltrials.gov) - Oct 22, 2015
P2, N=11, Terminated, Sponsor: Georgetown University
Trial primary completion date: Feb 2016 --> Oct 2016 Active, not recruiting --> Terminated; Poor accrual
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date: Vaginal Creams to Reduce Vaginal Erosion in Pessary Users (clinicaltrials.gov) - Oct 2, 2015
P2, N=0, Withdrawn, Sponsor: North Shore Long Island Jewish Health System
Active, not recruiting --> Terminated; Poor accrual N=246 --> 0 | Initiation date: Jan 2015 --> Apr 2015 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2015 --> Aug 2015
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Trial completion: Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone (clinicaltrials.gov) - Aug 27, 2015
P=N/A, N=13, Completed, Sponsor: University of Virginia
N=246 --> 0 | Initiation date: Jan 2015 --> Apr 2015 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2015 --> Aug 2015 Active, not recruiting --> Completed
- | Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
New P2 trial: Vaginal Creams to Reduce Vaginal Erosion in Pessary Users (clinicaltrials.gov) - Dec 13, 2014
P2, N=246, Not yet recruiting, Sponsor: North Shore Long Island Jewish Health System
- |||| Vivelle (estradiol transdermal system) / Sanofi, Hisamitsu, Novartis, Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Trial completion: Midlife Cholesterol Study (clinicaltrials.gov) - Nov 5, 2014
P4, N=120, Completed, Sponsor: Northwestern University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Trial primary completion date, Metastases: Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy (clinicaltrials.gov) - Jun 13, 2014
P2, N=11, Active, not recruiting, Sponsor: Georgetown University
Active, not recruiting --> Completed Trial primary completion date: May 2011 --> Jun 2015
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment closed, Metastases: Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy (clinicaltrials.gov) - Jun 13, 2014
P2, N=11, Active, not recruiting, Sponsor: Georgetown University
Trial primary completion date: May 2011 --> Jun 2015 Terminated --> Active, not recruiting
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment open: Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition (clinicaltrials.gov) - Feb 11, 2014
P=N/A, N=32, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Terminated --> Active, not recruiting Not yet recruiting --> Recruiting
- | Vivelle (estradiol transdermal system) / Sanofi, Hisamitsu, Novartis, Estreva oral (estradiol oral) / EMD Serono, Estrace (estradiol) / AbbVie
Trial completion: Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism (clinicaltrials.gov) - Dec 18, 2013
P4, N=41, Completed, Sponsor: Nemours Children's Clinic
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment closed: Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=13, Active, not recruiting, Sponsor: University of Virginia
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Premarin topical (equine conjugated estrogens) / Pfizer
Enrollment change: Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure (clinicaltrials.gov) - Dec 1, 2013
P=N/A, N=20, Completed, Sponsor: Stanford University
Recruiting --> Active, not recruiting N=60 --> 20
- Premarin topical (equine conjugated estrogens) / Pfizer
Trial completion: Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure (clinicaltrials.gov) - Dec 1, 2013
P=N/A, N=20, Completed, Sponsor: Stanford University
N=60 --> 20 Active, not recruiting --> Completed
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Trial initiation date: Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition (clinicaltrials.gov) - Aug 4, 2013
P=N/A, N=32, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Completed Initiation date: Feb 2013 --> Aug 2013
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment change, Metastases: Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy (clinicaltrials.gov) - Jun 18, 2013
P2, N=11, Terminated, Sponsor: Fox Chase Cancer Center
Initiation date: Feb 2013 --> Aug 2013 N=88 --> 11
- venlafaxine extended release / Generic mfg.
Trial completion: MsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal Symptoms (clinicaltrials.gov) - May 19, 2013
P=N/A, N=339, Completed, Sponsor: Fred Hutchinson Cancer Research Center
N=88 --> 11 Active, not recruiting --> Completed
- ||| Premarin topical (equine conjugated estrogens) / Pfizer, Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Trial completion, Combination therapy: DRIVE: Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms (clinicaltrials.gov) - Sep 20, 2012
P=N/A, N=58, Completed, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed Active, not recruiting --> Completed